Introduction {#sec1-1}
============

Among the hereditary motor sensory neuropathies, X-linked Charcot Marie Tooth Disease type 1 (CMTX) is the second most common disease. It is associated with mutations in Gap Junction B1 (GJB1) gene, which codes for connexin 32 protein present both in central and peripheral nervous systems.\[[@ref1][@ref2]\] Patients will have slowly progressive distal lower and upper limb weakness with foot deformities with minimal sensory findings and absent ankle jerks. Rarely, CMTX can also present with transient neurological deficits with signal changes in magnetic resonance imaging (MRI) of the brain.\[[@ref3][@ref4]\] In this communication, we describe a patient who was referred to us with the long-standing recurrent focal weakness with white matter changes in MRI, who was found to have CMTX disease.

Case Report {#sec1-2}
===========

A 19-year-old student was admitted with recurrent episodes of right hemiparesis and dysarthria from his age of 8 years. In 2002, he had right-sided hemiparesis with slurring of speech without aphasia developing over few minutes lasting for 10 hours. A computerized tomographic (CT) scan of brain was done, which was normal; electroencephalograph did not show any epileptiform discharges. He was treated with sodium valproate as a case of seizure with Todd\'s paralysis for next few years and he was asymptomatic. In 2010, he had transient mild distal weakness of the right upper limb while traveling in a bus, which lasted for 20 minutes. The following day he had right upper and lower limb weakness with slurring of speech lasting for 30 minutes. He was evaluated with a magnetic resonance imaging (MRI), which showed T2 hyperintense diffusion-restricting lesions in the splenium of the corpus callosum and internal capsule \[Figure [1a](#F1){ref-type="fig"}--[d](#F1){ref-type="fig"}\]. Demyelinating disease was suspected, and he was given oral steroids for 45 days. He improved completely in few days. In July 2013, he had 5 episodes of right hemiparesis without aphasia over 4 days, each lasting 20-30 minutes. Along with weakness, he also had numbness of right side of face, which lasted for about 20 minutes. Again, he was treated with steroids for one month and improved completely. In August 2013, he had 2 more episodes of right hemiparesis and right hemi facial sensory loss lasting 30 minutes. Imaging with MRI July showed bilateral periventricular and centrum semiovale diffusion restricting lesions \[Figure [1e](#F1){ref-type="fig"}--[h](#F1){ref-type="fig"}\]. He was referred to us with diagnosis of demyelinating disease for further management and consideration for immunomodulation.

![Magnetic resonance imaging of the brain: Diffusion-weighted sequences during 2010 episode (a-d) showing restricting lesions in left posterior limb of internal capsule and splenium of the corpus callosum. Lesions involving bilateral subcortical white matter and centrum semi ovale (e-h) during July 2013 episode. Resolution of the changes (i-l) in the repeat imaging done after 1.5 months. Arrows showing abnormalities](AIAN-18-111-g001){#F1}

Family history was significant in that maternal grandfather, mother, elder brother, and male cousins from the maternal side had a history of distal limb weakness and wasting. Mother and brother had been seen 15 and 5 years earlier by different treating teams at our hospital and diagnosis of CMT was made. In addition, the mother had a history of long-standing complex partial seizures, bipolar affective disorder, episodic weakness of limbs, and transient vision abnormalities, and the brother had two episodes of right hemiparesis lasting for few days with normal CT scan of the brain.

Examination revealed bilateral pescavus and hammer toes; no thickened nerves were seen. Motor examination revealed mild distal small muscle wasting in feet and hand, with mild toe grip weakness. Touch and joint position and pain sensation were normal but vibration sense was impaired in lower and upper limbs. Reflexes were sluggish in upper limbs and absent in lower limbs. Plantars were flexor bilaterally with inability to perform heel walking. Cardiac examination was normal and there were no bruits.

His routine hematological, biochemical, cardiac, immunological, thyroid, vitamin B12, homocysteine, electroencephalogram, and intra- and extracranial magnetic resonance angiography (MRA) were normal. Nerve conduction studies revealed sensory motor axonal and demyelinating neuropathy. All sensory nerve action potentials (SNAPs) were absent in both limbs, with motor nerve conduction velocities being 34-39 m/s with mild prolonged distal latencies. Visual-evoked potential showed prolonged P100 latency in both eyes as well as somatosensory-evoked potentials. Brainstem-evoked auditory responses were normal bilaterally. Auditory evaluation did not show any deafness. Serial imaging with MRI of the brain revealed T2 hyperintense signal changes in posterior limb of bilateral internal capsule (left \> right) and splenium of corpus callosum in 2010; these were diffusion-restricting \[Figure [1a](#F1){ref-type="fig"}--[d](#F1){ref-type="fig"}\]. In July 2013, MRI July revealed T2 hyperintense, T1 isointense diffusion-restricting lesions in bilateral centrum semi ovale and internal capsule \[Figure [1e](#F1){ref-type="fig"}--[h](#F1){ref-type="fig"}\]. Repeat MRI in August 2013 in our hospital showed disappearance of the centrum semi ovale lesions \[Figure [1i](#F1){ref-type="fig"}--[l](#F1){ref-type="fig"}\]. Nerve conduction studies of both his mother and brother were consistent with sensory motor axonal and demyelinating neuropathy. In 2013, MRI of the mother revealed diffusion-restricting lesions in the posterior limb of bilateral internal capsule (images not shown). Patient did not consent for a lumbar puncture.

The GJB 1 (CX32) gene at Xq13.1 was sequenced to investigate for the presence of mutation in the coding region and promoter 2 region. Molecular genetic testing was positive for c.425G\>A; p.R142Q mutation (hemizygous) in GJB1 gene. The C.425 G\>A mutation is a point mutation in coding region causing amino acid substitution from Arginine to glycine in 142^nd^ position. The patient was asymptomatic at the time of discharge for his episodic symptoms. He was treated conservatively without steroids and was given the information regarding his diagnosis and about the transient episodes associated with his disease.

Discussion {#sec1-3}
==========

Our patient presented with episodic transient focal motor symptoms over eleven years with resolving subcortical, splenial, and internal capsule white matter lesions. He and other family members had features of CMTX (with transient events in mother and brother) confirmed by genetic testing.

X-linked Charcot-Marie-Tooth disease presents with distal muscle involvement in form of weakness and sensory disturbances, hyporeflexia, and foot deformities. Motor nerve conduction velocities are reduced (males \> females). There are reports of various transient neurological dysfunctions in the form of hemiparesis, paraparesis, monoparesis, ataxia, and dysarthria lasting for few minutes to hours to days occasionally persistent deficits.\[[@ref3][@ref4][@ref5][@ref6][@ref7][@ref8][@ref9][@ref10][@ref11][@ref12][@ref13][@ref14][@ref15][@ref16]\] Almost all patients had childhood onset of symptoms, though few studies have reported adult onset of symptoms.\[[@ref5][@ref13]\] Attacks are provoked by stressors in the form of travel to high altitudes or infection but can also be spontaneous. MRI shows signal changes in corpus callosum, frontoparietal white matter, and rarely middle cerebellar peduncle, with sparing of subcortical U fibers. The lesions could persist for few months in the absence of symptoms. Around 240 different *GJB1* mutations have been described. The mutation c.425G\>A; p.R142Q mutation (hemizygous) has been previously described.\[[@ref17]\] In addition, there is report of this mutation in CMTX with associated deafness in one of the patient.\[[@ref18]\] However, there are no reports of transient neurological symptoms described with this mutation in the literature. As per our search, there are no genetically proven CMTX with transient neurological symptoms reported from India.

Connexin 32 protein is a gap junction protein found in Schwann cells in peripheral nerves (PN) and oligodendrocytes in the central nervous system. The gap junctions in PN form an easier way for the diffusion of small molecule sand ions between the covering myelin sheath layers. In the central nervous system, gap junctions help in coupling of oligodendrocytes and astrocytes. The Connexin 32 mutations lead to peripheral and central myelination defects and dysfunctions in gap junctions leading to loss of fluid regulation and diffusion restriction and transient neurological deficits.\[[@ref13][@ref14][@ref15][@ref16]\]

Compared to other patients reported in the literature, our patient was not a known case of CMTX when presented with transient neurological symptoms and had no predisposing factors (stress, infection, etc.). His mother and brother had features of CMTX with episodic transient neurological deficits. His mother also had psychiatric symptoms and long-standing seizures. This also may be a window of opportunity for further search in to the pathogenesis of weakness, white matter changes, and genetic defect in this disease.
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